| Literature DB >> 24657970 |
Ricard Cervera1, Ignasi Rodríguez-Pintó2, Serena Colafrancesco3, Fabrizio Conti3, Guido Valesini3, Cristina Rosário4, Nancy Agmon-Levin5, Yehuda Shoenfeld6, Claudia Ferrão7, Raquel Faria7, Carlos Vasconcelos7, Flavio Signorelli8, Gerard Espinosa2.
Abstract
The 'Task Force on Catastrophic Antiphospholipid Syndrome (CAPS)' was developed on the occasion of the 14th International Congress on Antiphospholipid Antibodies. The objectives of this Task Force were to assess the current knowledge on pathogenesis, clinical and laboratory features, diagnosis and classification, precipitating factors and treatment of this condition in order to address recommendations for future research. This article summarizes the studies analyzed by the Task Force, its recommendations and the future research agenda.Entities:
Mesh：
Substances：
Year: 2014 PMID： 24657970 DOI： 10.1016/j.autrev.2014.03.002
Source DB: PubMed Journal: Autoimmun Rev ISSN： 1568-9972 Impact factor: 9.754